March 26, 2015
Colorado’s biosimilars bill letting pharmacists provide patients with generic drugs in place of name-brand biotech medicines now needs only a governor’s signature to become law. The state House of Representatives passed the bill with only one ‘no’ vote on Tuesday, and it heads on to John Hickenlooper desk. Read more here.
February 27, 2014
Indiana Substitution Legislation Headed to Governor In Indiana, Senate Bill 262, has successfully moved through both chambers of the legislature with a strong vote of 92-5 in the State House. The legislation will now move to Governor Pence where it is hoped to quickly be considered. ASBM has written Governor Pence in strong support […]
October 22, 2013
On Oct 22, 2013, Andrew Spiegel, Executive Director of the Global Colon Cancer Association, testified in support of biosimilar legislation under consideration in IN. Indiana Health Finance Commission-GCCA Testimony
October 22, 2013
On Oct 22, 2013, Andrew Spiegel, Executive Director of the Global Colon Cancer Association, testified in support of biosimilar legislation under consideration in IN. Indiana Health Finance Commission-GCCA Testimony
October 10, 2013
Re: Support of HB 746-Biosimilars Thank you for providing this opportunity to speak about this important issue. My name is Andrew Spiegel. I am the Executive Director of the Global Colon Cancer Alliance. The Global Colon Cancer Alliance (GCCA) is the voice for colon cancer patients worldwide. Before running the GCCA, I was CEO and […]
October 10, 2013
Re: Support of HB 746-Biosimilars Thank you for providing this opportunity to speak about this important issue. My name is Andrew Spiegel. I am the Executive Director of the Global Colon Cancer Alliance. The Global Colon Cancer Alliance (GCCA) is the voice for colon cancer patients worldwide. Before running the GCCA, I was CEO and […]
March 27, 2013
State Activity More than 15 state legislatures have introduced legislation on substitution over the past few months and ASBM and our members have been very active sending letters of support, testifying at hearings and briefing state legislators on the issue of interchangeability and the need for physician notification. Virginia and North Dakota have both signed […]
March 27, 2013
State Activity More than 15 state legislatures have introduced legislation on substitution over the past few months and ASBM and our members have been very active sending letters of support, testifying at hearings and briefing state legislators on the issue of interchangeability and the need for physician notification. Virginia and North Dakota have both signed […]
December 21, 2012
On December 6th, Chairman Richard Dolinar, M.D., and Executive Director Michael Reilly toured a biologic manufacturing facility in Longmont, CO. Several ASBM members also participated on the tour which was arranged to help attendees better understand the complexities of manufacturing biologics.
December 21, 2012
On December 6th, Chairman Richard Dolinar, M.D., and Executive Director Michael Reilly toured a biologic manufacturing facility in Longmont, CO. Several ASBM members also participated on the tour which was arranged to help attendees better understand the complexities of manufacturing biologics.
